+ Watch AUXL
on My Watchlist
A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.
Investors should consider selling puts. You can achieve some very high annualized returns at strikes significantly below the current price. e.g.Sept 13 $15 strike, at $1.60, has 17% discount and 26% annualized return.
Sept 2013 low was about $17, expired profitably.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions